Fate Therapeutics Inc. Revenue 2011–2025
Fate Therapeutics Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Fate Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 1.3 M, a 20.26% decrease year-over-year.
- Fate Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 6.6 M, a 52.05% decrease year-over-year.
- Fate Therapeutics Inc. annual revenue for 2025 was 6.6 M, a 51.24% decrease from 2024.
- Fate Therapeutics Inc. annual revenue for 2024 was 13.6 M, a 78.55% decrease from 2023.
- Fate Therapeutics Inc. annual revenue for 2023 was 63.5 M, a 34.03% decrease from 2022.
- Fate Therapeutics Inc. annual revenue for 2022 was 96.3 M.
Fate Therapeutics Inc. (FATE) — Frequently Asked Questions
Fate Therapeutics Inc. (FATE) is a publicly traded US company. It has a market capitalization of $233M. In fiscal 2025 it reported revenue of $7M and net income of -$136M. Explore FATE's stock price, financial statements, earnings history, margins and key ratios below.
What is Fate Therapeutics Inc.'s market cap?
Fate Therapeutics Inc. (FATE) has a market capitalization of $233M.
What is the FATE stock price?
FATE trades at $1.97 (+5.08% on the day).
How much revenue does Fate Therapeutics Inc. make?
Fate Therapeutics Inc. reported revenue of $7M in fiscal 2025.
Is FATE profitable?
In fiscal 2025, Fate Therapeutics Inc. reported net income of -$136M.